仁和药业: 半年报董事会决议公告

Core Points - The board of directors of Renhe Pharmaceutical Co., Ltd. held its second meeting of the tenth session on August 22, 2025, where all nine directors were present and the meeting complied with relevant laws and regulations [1] Group 1 - The board approved the full text and summary of the 2025 semi-annual report, confirming that the report accurately reflects the company's actual situation without any false records or misleading statements [1][2] - The voting results for this resolution were unanimous, with 9 votes in favor, 0 against, and 0 abstentions [2][3] Group 2 - The board also approved a special report on the storage and use of raised funds for the first half of 2025, stating that the company complied with relevant regulations and that the actual use of raised funds was legal and compliant [2] - This resolution also received unanimous approval, with 9 votes in favor, 0 against, and 0 abstentions [2][3]